I hope that report is correct as it indicates ANP has a licencing deal again with Teva.
I suspect they have reported historical information which is no longer correct as the Teva deal went sour over 2 years ago.
get this ms market potential of $17 billion, page-2
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $90.15M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.0¢ | $52.56K | 502.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 176914 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 217753 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |